Leonardo Roever: New Perspectives on Thromboinflammation in Acute Ischemic Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Umberto Pensato et al, published in Stroke, adding:
”Thromboinflammation in Acute Ischemic Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities
Despite major advances in intravenous thrombolysis and endovascular thrombectomy, nearly half of patients with acute ischemic stroke fail to achieve functional recovery, even after technically successful recanalization.
The gap between recanalization and reperfusion—the mismatch between angiographic vessel opening and the restoration of tissue-level perfusion—has brought thromboinflammation (the pathological interplay between coagulation and innate immunity) to the forefront of stroke biology.
This review outlines key thromboinflammatory challenges—such as recanalization resistance, the no-reflow phenomenon, and reperfusion injury—and discusses the therapeutic opportunities emerging from this context.”
Title: Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities
Authors: Umberto Pensato, Tyler Henry, Andrew M. Demchuk, Giuseppina Caligiuri
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring